Real-time enrollment status for this migraine clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 5:03 AM UTC
| NCT Number | NCT05125302 |
| Recruiting Status | Recruiting |
| Condition | Migraine |
| Phase | PHASE3 |
| Target Enrollment | 1,059 participants |
| Active Locations | 125 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | September 14, 2026 (Sep 14, 2026) |
As of October 18, 2026: Clinical trial NCT05125302 is currently recruiting participants. This phase3 study for migraine is actively seeking new participants at 125 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05125302 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 125 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05125302 was last updated Sep 14, 2026 (September 14, 2026). HelloStudys verifies this status automatically.